Integrated Drug Discovery
Integrated Drug Discovery: Accelerating Your Path to Novel Therapeutics
Our team of over 2,000 dedicated researchers and scientists delivers exceptional quality in drug discovery, development, and preclinical testing. As an OECD – GLP – certified CRO, we partner with global pharmaceutical and biotech companies to accelerate therapeutic development.
Anthem's Integrated Preclinical Capabilities
Our platforms are designed to help Discovery for both Large and Small Molecules. Our AAALAC-accredited vivarium, spanning 30,000 sq. ft. with 38 specialized animal rooms, supports high-quality research across a range of studies, including:
Regulatory Toxicology
Ensuring safety and compliance with acute to chronic toxicity assessments, toxicokinetics, and dose formulation analysis.
Reproductive Toxicology
Assessing safety related to human and environmental health with developmental and multi-generational reproductive toxicity studies.
Genetic Toxicology
Evaluating mutagenic and genotoxic potential through AMES tests, chromosomal aberration tests, and alkaline Comet assays.
Safety Pharmacology
Mitigating risks early with evaluations of respiratory, CNS, and cardiovascular functions, alongside in vitro hERG assays.
In Vivo Pharmacology
Efficacy testing using relevant animal models for oncology, pain, inflammation, metabolic disorders, autoimmune diseases, and anti-infective studies.
DMPK (Drug Metabolism and Pharmacokinetics)
Determining pharmacokinetic profiles through physicochemical properties, absorption, distribution, metabolism, excretion, and drug-drug interaction studies.
In Vitro Alternate Assays
Providing humane and ethical alternatives with skin and eye irritation, phototoxicity, and sensitization testing.
Exceptional Quality
Ethical Standards & AAALAC Accreditation
Expert Team of 2,000+ researchers and scientists
